Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.4.13 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.358EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.159EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.510EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.91EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.227EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.555EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.513EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XACEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EJ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.31.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.66EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
BA.1.21.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ES.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.479EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.437EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.371EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used